Clin2
NCT06228677Possibly a fitRecruiting

Catecholamine levels during adrenal artery embolization

Resistant HypertensionSecondary HypertensionSecondary Hypertension to Endocrine DisordersPrimary Aldosteronism

Part of Hormones & metabolism clinical trials.

This trial measures hormone levels in blood during a procedure to treat high blood pressure caused by an adrenal gland problem. It may help doctors understand how the body responds during treatment.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
196 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older
  • You have primary aldosteronism, a condition where your adrenal glands make too much of a hormone that raises blood pressure
  • Your blood pressure is above normal, either at the doctor's office or during a 24-hour check
  • A CT scan shows changes in your adrenal glands like thickening or small lumps
  • You have had high blood pressure for at least 6 months
  • You are not pregnant, breastfeeding, or planning to become pregnant in the next year

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06513676Recruiting
Adrenal artery treatment for aldosteronism study

This study tests a procedure that blocks tiny arteries in the adrenal gland to treat high blood pressure and low potassium caused by aldosteronism. It may be an option if you cannot take medications or cannot have surgery.

Ürümqi, Xinjiang
NCT06513585Recruiting
Two treatments for primary aldosteronism: embolization vs. surgery

This study compares two treatments for primary aldosteronism (a condition causing high blood pressure due to an adrenal gland issue). One treatment is a minimally invasive procedure called superselective embolization, and the other is keyhole surgery. This trial aims to see which is better and safer for patients.

Ürümqi, Xinjiang
NCT05561361Recruiting
Test treatment for primary aldosteronism and blood vessel function

This trial studies whether a specific treatment (related to spironolactone/aldosterone support) can improve how well your blood vessels work in people with primary aldosteronism. It may help reduce blood pressure risk by improving blood vessel health.

Nanchang
NCT05501080Recruiting
Testing a hormone treatment to improve heart changes in PA

This trial tests whether a treatment called SAAE can improve “ventricular remodeling,” meaning changes in the heart muscle, in people with primary aldosteronism (PA). It may help the heart work more efficiently by targeting the cause of high aldosterone levels.

Nanchang
NCT06737848Not yet recruiting
Comparing two ways to sample vein blood from the adrenal gland using an arm vein

This trial tests whether using one small tube (catheter) in a vein in the arm is as effective as using two tubes to collect blood from the adrenal glands to help diagnose high blood pressure caused by hormone issues.

NCT04409431Recruiting
Spironolactone plus adrenal nerve treatment for adrenal overactivity

This trial studies whether blocking part of the adrenal blood supply (“adrenal artery ablation”) along with spironolactone can improve hormone-driven high blood pressure caused by primary aldosteronism. It may help people who have confirmed adrenal overactivity and do not want surgery.

Chongqing, Chongqing Municipality

Hear when a new Resistant Hypertension trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.